Searched for
WANBURY PHARMA
- Stock market update: Nifty Pharma index falls 0.08%The Nifty Pharma index closed 0.08 per cent down at 21633.2.
Stock market update: Nifty Pharma index falls 0.52% in a weak marketThe Nifty Pharma index was trading 0.52 per cent down at 21537.6.- Stock market update: Nifty Pharma index falls 0.33% in an upbeat marketThe Nifty Pharma index was trading 0.33 per cent down at 12627.45.
- Stock market update: Nifty Pharma index falls 0.26%The Nifty Pharma index closed 0.26 per cent down at 13052.9.
- Corporate Radar: PNB, Union Bank to turn ex-dividend, SBI AGM; Q4 results, bonus issues & moreWednesday is also the record date for dividends by Britannia Industries, Bank of Maharashtra, Agro Tech Foods, Bliss GVS Pharma, Bharat Sea...
- Market Movers: Venky's, airline stocks, YES Bank hit hard; 44 stocks flash 'sell' signalsAirline shares fell up to 5 per cent, as travel is getting hit due to the fast spreading disease.
- Stock market update: 17 stocks hit 52-week highs on NSEAmong the stocks that touched their 52-week highs were Cubex Tubings and Fairchem Speciality.
- API makers surge up to 110% in 50 days as virus hits Chinese exportsBrokerage sees coronavirus crisis as a positive for companies like Granules India and Natco.
- Market outlook: Nifty50 needs to sail past key resistance at 10,500On Monday,10,500 and 10,565 levels should play out as immediate resistance for Nifty50.
- Fourteen stocks in focus on Tuesday, 29 November 2016Sun Pharma launched BromSite solution, marked for treatment of postoperative inflammation and prevention of ocular pain in patients undergo...
- After India, European Union to probe Wanbury Pharma for illegal exportEMA’s involvement in the case comes two weeks after the Drugs Controller General of India gave an export certificate to Wanbury to supply d...
- Thane FDA sends show-cause notice to Wanbury Pharma“We have sent a show cause notice to the company and are waiting for a reply,” said Viraj Paunikar, Assistant Commissioner, Thane FDA, in a...
- Arvind Remedies to invest Rs 190 crore in drug manufacturing unit"We are investing Rs 190 cr in our Chennai facility to make oral solids, dry powders and multi-dosage forms along with a couple of patented...
- Nearly 20% of $7-billion foreign currency convertible bonds face default risk this year, says FitchNearly 20% of the $7-bn FCCBs face default risk this year as investors demand funds back due to languishing stock prices.
- Input costs, short supplies hit bulk drug makers hardRising input costs and short supplies have hit the fortunes of the domestic active pharmaceutical ingredient (API) industry, especially in ...
- Stocks to watch: M&M, Rolta, Modern MillsM&M and French carmaker Renault are discussing the possibility of selling cars made in Renault-Nissan’s manufacturing facility in Chennai t...
- Wanbury raises euro 15 million through FCCBsPharma major Wanbury Ltd on Tuesday said it has raised 15 million euros through Foreign Currency Convertible Bonds listed on the Luxembourg...
- Wanbury acquires Spanish drugmaker for Rs 240 crWanbury on Monday said it has agreed to acquire Spanish drugmaker Industria Farmaceutica Cantabri’s branded generic business for Rs 240 cro...
- Wanbury to acquire Spanish CoThe company will also seek shareholders approval through postal ballot for making investments of upto Rs 400 crores for acquisitions or loa...
- Novartis in a soup over snapping deal with distributorIn a rare case of its kind, a magisterial court in Mumbai has ordered the police to register First Information Report against pharma major ...
Load More
